All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @notanothermodel on TikTok · 11s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @notanothermodel's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00We're in the shapes and we're in the sea
  2. 0:04Still fires on our own
  3. 0:06Why are you here?
  4. 0:08I'm here now

50 pounds in 90 days on peptides: what the evidence actually says

NOT A MODEL

TikTok creator

17.0K viewsWatch on TikTok

Quick answer

The video caption implies peptide-assisted loss of 50-plus pounds in 90 days, but no specific peptide or protocol is disclosed in the available transcript. Clinical trial data for GLP-1 receptor agonists, the most evidence-backed class of peptides used for weight loss, shows average losses of 15-21% of body weight over 68-72 weeks, not 90 days. Weight regain after discontinuation of these agents is well-documented, directly contradicting any claim that results are permanent.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For 50 pounds in 90 days on peptides: what the evidence actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

50 pounds in 90 days on peptides: what the evidence actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "50 pounds in 90 days on peptides: what the evidence actually says" from NOT A MODEL. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video caption implies peptide-assisted loss of 50-plus pounds in 90 days, but no specific peptide or protocol is disclosed in the available transcript.

The reason this review is not generic is the source wording and the canonical claim label "peptides only 90 days 50 pounds gone forever peptide transformation b." In this clip, the useful excerpt is: "We're in the shapes and we're in the sea Still fires on our own Why are you here?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Tirzepatide, the most effective approved GLP-1/GIP agonist, produced up to 20.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video caption implies peptide-assisted loss of 50-plus pounds in 90 days, but no specific peptide or protocol is disclosed in the available transcript.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video caption implies peptide-assisted loss of 50-plus pounds in 90 days, but no specific peptide or protocol is disclosed in the available transcript. Clinical trial data for GLP-1 receptor agonists, the most evidence-backed class of peptides used for weight loss, shows average losses of 15-21% of body weight over 68-72 weeks, not 90 days. Weight regain after discontinuation of these agents is well-documented, directly contradicting any claim that results are permanent.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) found semaglutide produced an average 14.9% body weight loss over 68 weeks, not 90 days.
  • Tirzepatide, the most effective approved GLP-1/GIP agonist, produced up to 20.9% weight loss in SURMOUNT-1 (Jastreboff et al., 2022, NEJM) over 72 weeks.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The STEP 1 trial (Wilding et al., 2021, NEJM) found semaglutide produced an average 14.9% body weight loss over 68 weeks, not 90 days.
  • Tirzepatide, the most effective approved GLP-1/GIP agonist, produced up to 20.9% weight loss in SURMOUNT-1 (Jastreboff et al., 2022, NEJM) over 72 weeks.
  • Wilding et al. (2022, Diabetes, Obesity and Metabolism) documented two-thirds weight regain within 12 months of stopping semaglutide, making 'gone forever' claims scientifically unsupported.
  • Research peptides like CJC-1295 and ipamorelin have no published human trials demonstrating significant standalone fat loss comparable to GLP-1 agents.
  • MK-677 studies (Svensson et al., 1998, JCEM) show modest body composition changes tied to GH and IGF-1 elevation, not dramatic weight loss outcomes.
  • A rate of 50 pounds in 90 days equals roughly 3.9 pounds per week, which exceeds medically supervised safe loss targets and may reflect water, muscle, or non-fat tissue changes.
  • Compounded peptides are not verified equivalents of FDA-approved formulations and have no guaranteed potency, purity, or safety data equivalent to regulated drugs.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @notanothermodel actually say?

Honestly? Not much. The transcript here is either corrupted or completely off-topic, reading like song lyrics: "We're in the shapes and we're in the sea / Still fires on our own." There is no spoken claim about peptides, dosing, or any specific protocol to evaluate directly.

What we do have is the caption: "ONLY 90 DAYS… 50+ pounds gone forever" with a peptide hashtag front and center. That caption is doing real work. It implies a peptide-assisted transformation of more than 50 pounds in 90 days, framed as permanent weight loss. That is the claim we need to examine, even if the creator never said it out loud.

The hashtags reinforce this: #peptide, #biohacking, #looksmaxing. The audience landing on this video is not thinking about caloric deficits. They are thinking GLP-1s, semaglutide analogs, or research peptides. That context matters.

Does the science back this up?

50-plus pounds in 90 days is at the extreme edge of what clinical trials document, even with the most aggressive pharmaceutical interventions. No peer-reviewed peptide study supports that rate as typical or safe.

The most relevant data comes from GLP-1 receptor agonist trials. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed semaglutide produced roughly 14.9% body weight loss over 68 weeks, not 90 days. Tirzepatide fared better in SURMOUNT-1 (Jastreboff et al., 2022, NEJM), with up to 20.9% loss over 72 weeks. Neither trial produced 50-plus pounds in three months as a typical outcome.

Research peptides like CJC-1295, ipamorelin, or MK-677 have even thinner evidence for weight loss specifically. MK-677 studies (Svensson et al., 1998, Journal of Clinical Endocrinology and Metabolism) show increased growth hormone and IGF-1, with body composition changes that are modest and slow. No published trial shows 50-plus pounds of fat loss in 90 days from any peptide regimen.

What did they get wrong (or right)?

The caption claim of "50+ pounds gone forever" is misleading on two counts. First, the timeline is implausible as a peptide-specific outcome. Second, no weight loss intervention has a scientific basis for claiming results are "forever." Weight regain after GLP-1 discontinuation is well-documented: Wilding et al. (2022, Diabetes, Obesity and Metabolism) showed participants regained two-thirds of lost weight within a year of stopping semaglutide.

To be fair, transformation results are real for some people. Peptide-assisted or GLP-1-assisted weight loss does work for a meaningful subset of patients. The problem is the framing, not the existence of results. Presenting an outlier outcome with no context about medication, diet, exercise, or individual variables is how misinformation spreads even when the underlying experience is genuine.

  • The 90-day timeline for 50-plus pounds is not supported by clinical trial averages.
  • "Gone forever" contradicts published data on weight regain after peptide or GLP-1 discontinuation.
  • No specific peptide is named, making independent fact-checking of the protocol impossible.

What should you actually know?

If you are considering peptide therapy for weight loss, the evidence hierarchy matters. GLP-1 receptor agonists have the strongest clinical backing. Research peptides like ipamorelin or CJC-1295 are used off-label with limited human trial data, and compounded versions are not equivalent to FDA-approved formulations in terms of verified potency or purity.

The FDA and FTC have both flagged social media weight loss content that uses before-and-after framing to imply typical results. Individual outcomes are not population-level evidence. A single transformation video, however dramatic, tells you nothing about what will happen to you.

Sustainable fat loss rates in medically supervised programs typically run 1-2 pounds per week. Fifty pounds in 90 days works out to roughly 3.9 pounds per week, which would require an extraordinary and sustained caloric deficit or significant water and muscle loss alongside fat. That distinction never gets made in caption-only content like this.

Talk to a licensed provider before starting any peptide protocol. Understand what is actually in what you are taking, especially from compounding pharmacies, and ask about the evidence behind any specific peptide being recommended for weight loss.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

NOT A MODEL · TikTok creator

17.0K views on this video

ONLY 90 DAYS… 50+ pounds gone forever #peptide #transformation #biohacking #looksmaxing #fitnessjourney on

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the step 1 trial (wilding et al., 2021, nejm) found?

The STEP 1 trial (Wilding et al., 2021, NEJM) found semaglutide produced an average 14.9% body weight loss over 68 weeks, not 90 days.

What does the video say about tirzepatide, the most effective approved glp-1/gip agonist, produced up to?

Tirzepatide, the most effective approved GLP-1/GIP agonist, produced up to 20.9% weight loss in SURMOUNT-1 (Jastreboff et al., 2022, NEJM) over 72 weeks.

What does the video say about wilding et al. (2022, diabetes, obesity?

Wilding et al. (2022, Diabetes, Obesity and Metabolism) documented two-thirds weight regain within 12 months of stopping semaglutide, making 'gone forever' claims scientifically unsupported.

What does the video say about research peptides like cjc-1295?

Research peptides like CJC-1295 and ipamorelin have no published human trials demonstrating significant standalone fat loss comparable to GLP-1 agents.

What does the video say about mk-677 studies (svensson et al., 1998, jcem) show modest body?

MK-677 studies (Svensson et al., 1998, JCEM) show modest body composition changes tied to GH and IGF-1 elevation, not dramatic weight loss outcomes.

What does the video say about a rate of 50 pounds in 90 days equals roughly?

A rate of 50 pounds in 90 days equals roughly 3.9 pounds per week, which exceeds medically supervised safe loss targets and may reflect water, muscle, or non-fat tissue changes.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by NOT A MODEL, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.